Premium
Interventions to slow the progression of myopia
Author(s) -
OHLENDORF A
Publication year - 2014
Publication title -
acta ophthalmologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.534
H-Index - 87
eISSN - 1755-3768
pISSN - 1755-375X
DOI - 10.1111/j.1755-3768.2014.2713.x
Subject(s) - medicine , psychological intervention , optometry , ophthalmology , muscarinic acetylcholine receptor , refractive error , clinical trial , eye disease , receptor , psychiatry
Purpose The purpose of the talk is to assess the effectiveness of different strategies, including optical refractive corrections with either spectacles or contact lenses as well as pharmaceutical approaches, to control the progression of myopia. Methods Interventions that have been explored to slow the progression of myopia include monofocal, bifocal and multifocal spectacles, cycloplegic drops, drugs to lower the intraocular pressure, muscarinic receptor antagonists and contact lenses. The scientific background for the different interventions will be presented and results of clinical trials will be reviewed. Results Clinical trials have shown negligible positive effects of progressive additional and bifocal lenses on myopia progression compared to single vision lenses. Observed beneficial effects of rigid gas permeable contact lenses could be related to the ethnicity of participants. The largest positive effects for slowing myopia progression were exhibited with anti‐muscarinic medications. Conclusion Further investigations of myopia control must be conducted in order to find treatments which are clinically meaningful and beneficial. The leading potential candidates at this time are anti‐muscarinic topical medications.Commercial interest